Cooley advised 2048 Ventures on the deal. 2048 Ventures, an early-stage venture capital firm, announced the closing of its oversubscribed Fund II at $67 million. 2048 Ventures...
2048 Ventures’ $67 Million Fund Closing
eFishery’s $90 Million Series C Financing Round
Cooley LLP advised eFishery on the deal. eFishery, an Indonesian agtech startup company, announced its $90 million Series C financing round, which marks the largest fundraise...
Immatics’ License Agreement With Bristol Myers Squibb
Cooley LLP advised Immatics on the deal. Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced its license, development...
Blue Delta Capital Partners’ $215 Million Fund Closing
Cooley advised Blue Delta Capital Partners on the deal. Blue Delta Capital Partners, a venture capital firm based in Tysons, Virginia, announced the closing of its oversubscribed...
Rocket Companies’ $1.275 Billion Acquisition of Truebill
Cooley advised Truebill on the deal, while Paul, Weiss, Rifkind, Wharton & Garrison advised Rocket Companies. Truebill, a personal finance app that helps consumers manage their...
Biote’s Business Combination Agreement with Haymaker Acquisition Corp.
Cooley advised Biote on the deal. Biote, a medical practice-building business within the hormone optimization space, announced its definitive business combination agreement with special purpose acquisition company...
Norwest Venture Partners’ $3 Billion Fund Closing
Cooley advised Norwest Venture Partners on the deal. Norwest Venture Partners announced the closing of a $3 billion fund, Norwest Venture Partners XVI, which brings its total...
Alpargatas’ $475 Million Series B Investment in Rothy’s
Mayer Brown represented Alpargatas S.A. in the transaction while Cooley advised Rothy. Alpargatas S.A., a Brazil-based, global footwear company creator of the famous flip flop “Havaianas,”...
Great Hill Partners’ Investment in Prodege
Cooley LLP advised Prodege on the deal. Prodege, a cutting-edge marketing and consumer insights platform, announced its definitive agreement to secure a major investment from private equity...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
Asymchem’s $917 Million Hong Kong Listing
Latham & Watkins LLP advised the underwriters in the transaction while Cooley and JunHe represented Asymchem Laboratories. Asymchem Laboratories (Tianjin) Co., Ltd (Asymchem), a leading drug...
Costanoa Ventures’ $340 Million Fund Closing
Cooley LLP advised Costanoa Ventures on the deal. Costanoa Ventures announced the closing of two new funds totaling $340 million. The two new funds, the $225 million...